Labcorp
Search results
3 days ago · SECAUCUS, N.J. and TORONTO, July 3, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community laboratory tests for millions of Canadians, for a value of approximately CAN $1.35 billion (approximately USD $985 million), including net debt.
3 days ago · Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community ...
2 days ago · Quest Diagnostics’ recent announcement to acquire LifeLabs, a major player in community laboratory tests in Canada, for $985 million signifies a substantial expansion outside of the United States.
20 hours ago · Quest Diagnostics ( NYSE:DGX - Get Free Report) last posted its quarterly earnings results on Tuesday, April 23rd. The medical research company reported $2.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.18. Quest Diagnostics had a return on equity of 15.52% and a net margin of 9.11%.
3 days ago · Quest Diagnostics said on Wednesday it would acquire Canada-based LifeLabs from pension plan owner OMERS for about C$1.35 billion, or about $985 million, including net debt.
3 days ago · Quest Diagnostics has also announced a quarterly cash dividend of $0.75 per share, further demonstrating its commitment to shareholder value. In terms of leadership changes, ...
3 days ago · Save for later. NEW YORK – Quest Diagnostics said Wednesday that it is acquiring Canadian laboratory firm LifeLabs for roughly C$1.35 billion (US$985 million). According to Quest, the transaction will generate roughly C$970 million in annual revenues and will be accretive to adjusted earnings per share in the first year after closing.
